Holdings of BML Capital Management, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 14 in 1 countries
- Top ten
- 94.9 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Aclaris Therapeutics Inc | 14,250,000 | 53.4M $ | |
| 2 | Atea Pharmaceuticals Inc | 7,058,657 | 38M $ | |
| 3 | Oramed Pharmaceuticals Inc | 3,167,231 | 10.8M $ | |
| 4 | Tilly's Inc | 2,150,000 | 8.7M $ | |
| 5 | OUTSET MEDICAL INC | 1,902,201 | 7.3M $ | |
| 6 | PMV Pharmaceuticals Inc | 5,320,000 | 6.6M $ | |
| 7 | CarMax Inc | 155,000 | 6.4M $ | |
| 8 | Kezar Life Sciences Inc | 720,787 | 5.3M $ | |
| 9 | Instil Bio Inc | 645,600 | 5.3M $ | |
| 10 | Target Corp | 37,500 | 4.5M $ | |
| 11 | Kraft Heinz Co/The | 125,000 | 2.8M $ | |
| 12 | Janux Therapeutics Inc | 154,961 | 2.2M $ | |
| 13 | Pliant Therapeutics Inc | 1,546,137 | 1.9M $ | |
| 14 | IMAGENEBIO INC | 200,730 | 1M $ |
Sector breakdown
- Consumer discretionary 2.9 %
- Consumer staples 1.8 %
- Unattributed 95.2 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 14 | 154.4M $ | 100.00 % |
Cite this page
Titelia. "Holdings of BML Capital Management, LLC". https://titelia.com/en/funds/US13F1616824